v3.25.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 $ 77,871,584 $ 877 $ (66,900,725)
Beginning balance, Shares at Dec. 31, 2023   6,186,280      
Stock-based compensation expense 53,434   53,434    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 397,607 $ 291 397,316    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   290,564      
Other comprehensive income loss (2,677)     (2,677)  
Net Income (Loss) (4,649,635)       (4,649,635)
Ending balance at Mar. 31, 2024 6,776,651 $ 6,477 78,322,334 (1,800) (71,550,360)
Ending balance, Shares at Mar. 31, 2024   6,476,844      
Beginning balance at Dec. 31, 2024 $ 94,866,280 $ 69,362 189,254,777 (37,248) (94,420,611)
Beginning balance, Shares at Dec. 31, 2024 69,362,439 69,362,439      
Stock-based compensation expense $ 2,042,196   2,042,196    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 2,460,501 $ 830 2,459,671    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   829,849      
Contingently issuable common stock subject to vesting criteria, shares   4,149,252      
Contingently issuable common stock subject to vesting criteria, value 4,149 $ 4,149      
Other comprehensive income loss 36,281     36,281  
Net Income (Loss) (13,678,735)       (13,678,735)
Ending balance at Mar. 31, 2025 $ 85,730,672 $ 74,341 $ 193,756,644 $ (967) $ (108,099,346)
Ending balance, Shares at Mar. 31, 2025 74,341,540 74,341,540